MicroPort CardioFlow Medtech Corporation will hold an Extraordinary General Meeting on December 15, 2025, where shareholders will vote on a proxy proposal related to a very substantial acquisition and connected transaction involving the issuance of new shares under a specific mandate in connection with the acquisition of a target group. The Independent Board Committee and Independent Shareholders have been advised on the transaction, with a recommendation to vote in favor of the proposal.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microport Cardioflow Medtech Corporation published the original content used to generate this news brief via via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251125-11926788), on November 24, 2025, and is solely responsible for the information contained therein.
Comments